Business Details
40 Years
experience
Your Partner for Value-Added Pharmaceuticals
Established in 1986, we are a European specialty pharmaceutical group formed through the strategic combination of three companies across the UK and Ireland. Our focus lies in developing, in-licensing, acquiring, and commercialising value-added medicines, with a portfolio exceeding 200 products. We serve the NHS and private healthcare sectors across the UK, Ireland, and Europe through a network of 50+ international partners. Our commitment to innovation is demonstrated by annual investments of up to 10% EBITDA in product development. With over 200 colleagues and production sites in the UK and Ireland, we maintain a strong presence in anti-infectives, oncology, pain management, and ophthalmology.Our EcoVadis Gold Rating for sustainability and membership in Medicines for Europe underscore our industry leadership. We operate as a privately-owned, asset-light organisation with a clear five-year growth strategy. Our over-labelling services support operational efficiencies for 200+ UK healthcare customers. Through strategic M&A activity and commercial expertise, we deliver medicines to patients while meeting business expectations. Our leadership team brings decades of pharmaceutical experience across general management, finance, operations, and regulatory affairs.
Services
Pharmaceutical Development
Medicine Commercialisation
Over-Labelling Services
Beta-Lactam Production
Hospital Supply Solutions
Details
- Year established: 1986
Highlights and features
- We have over 35 years of combined experience in pharmaceutical development and distribution
- Our portfolio includes 200+ value-added medicines across key therapeutic areas
- We maintain a 10% annual EBITDA investment in product development
- Our network spans 50+ international partners across Europe and beyond
- We operate GMP-certified manufacturing and over-labelling facilities in the UK and Ireland
Associations and certifications
- EcoVadis Gold Rating
What people say
Strong product portfolio
Experienced leadership team
Sustainable operations
Services
Pharmaceutical Development
We specialise in developing value-added medicines through strategic in-licensing and product acquisitions. Our expertise covers formulation development, regulatory compliance, and commercialisation across key therapeutic areas. With dedicated laboratories in Huddersfield and Dublin, we deliver innovative solutions that meet evolving healthcare needs while maintaining strict quality standards.
Over-Labelling Services
Our Measham-based facility provides comprehensive over-labelling solutions for healthcare providers. This service enhances operational efficiency for NHS trusts, private hospitals, and community services by ensuring accurate product identification and compliance with regulatory requirements across the UK healthcare sector.
Beta-Lactam Production
Athlone Laboratories operates a dedicated beta-lactam manufacturing plant in Ireland. This facility produces oral dose antibiotics under strict quality controls, serving both domestic and international markets with essential anti-infective treatments while maintaining contamination-free production standards.
Hospital Supply Solutions
We supply critical medicines to UK hospitals through our extensive distribution network. Our hospital business team maintains strong relationships with NHS trusts and private healthcare providers, ensuring reliable access to essential treatments in oncology, pain management, and other specialist areas.
Strategic Partnerships
Our business development focuses on creating strategic alliances across Europe. Through in-licensing agreements, distribution partnerships, and product development collaborations, we expand our portfolio while leveraging partner expertise to accelerate market access for innovative treatments.
People
Terry Petersen
Chief Executive Officer
Over 20 years' pharmaceutical leadership experience, including SME business development and M&A expertise. Previously led European business carve-out for CNX Therapeutics in 2021.
Olga Lund
Chief Financial Officer
20+ years pharmaceutical finance experience with expertise in international transactions and corporate acquisitions. Previously CFO at CNX Therapeutics with City of London background.
David Wright
Chief Business Officer
Two decades in pharmaceutical and medical device industries with specialist M&A and integration experience across UK, US and Ireland markets through multiple corporate transactions.
Clare Silcock
Operations Director
20+ years pharmaceutical operations experience covering R&D, clinical trials and commercial supply chains with expertise in ERP implementation and supply chain optimisation.
Derek Martin
Director of Regulatory and Quality Operations
Two decades of pharmaceutical quality and regulatory expertise including quality management system implementation and manufacturing authorisation award processes across multiple production sites.
Questions
What therapeutic areas do you specialise in?
We focus on anti-infectives, oncology, pain management, ophthalmology, and women's health.
How do you ensure medicine quality?
Through GMP-certified manufacturing, rigorous quality control, and regulatory compliance across all production sites.
Do you supply to private healthcare providers?
Yes, we serve both NHS and private healthcare sectors across UK and Ireland.
What is your product development strategy?
We combine in-house R&D with strategic in-licensing and acquisitions to expand our portfolio.